chrisvoncsefalvay/vaers-outcomes huggingface dataset:
11 days, post vax, her eyelashes and eyebrows fell out. Her eyebrows did begin to grow back when...She received the 2nd Hep-B shot and after 11 days, post vax, her eyebrows fell out. The few remaining eyelashes fell out, too. The follow up report received on 12/13/00 states, "She comes in today for evaluation of localized hair loss in th eyebrows and eyelashes. This has been ongoing now for about a two week period that the mother has noticed. She has not had any itching or discomfort around the eyes. She has not been plucking at the eyebrows or eyelashes as near as she and her mother know. She does wear glasses but does not wear any contacts. Has not had any redness or discharge. On exam today her hair is normal without any hairloss, without any lesions, scabies or mites within the hair. She does have hair loss in the eyebrow more on the right then on the left and in the eyelashes with some broken hairs as well as absent hairs. The eyes themselves are clear without any signs of infection or drainage. HEENT is otherwise normal. NECK is supple. No thyromegaly or masses. LUNGS are clear. HEART is RRR without murmurs. ABDOMEN is benign. Localized alopecia to be eyebrow and eyelash area of uncertain etiology. I wanted to try her on some Decadron ophthalmic ointment to see if this is an inflammatory response but this was not available at the pharmacy. Therefore seh is placed on Cortisporin and is going to use that tid for at least a week and follow back if not getting some new hair growth within a three week period."
Woke up next morning with buzzing/ringing in left ear. Thought it was from headache I had. Now  every time I?m in silence I hear it.
Paxlovid taken after vaccine.; Paxlovid taken after vaccine.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (BNT162B2 OMI XBB.1.5), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Paxlovid taken after vaccine.". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient experienced several seizures after vaccine administration.  She also experienced the same symptoms after her first dose of vaccine.  She was advised to have her second dose administered in Urgent Care so that appropriate monitoring could be performed.
Saturday 1-19-08 developed chills and low grade fever, arm swollen and sore dull ache.
50 lesions, chest, face and legs. Afebrile lesions since morning.
5-inch diameter itchy rash at injection site developed 6 days after shot.  The internet tells me this is "covid arm."
pt recvd vax & exp weakness & tingling in arms & face; 24-48 hrs began dizziness, muscle aches; 4 days later devel flu like symptoms; t 102, diaphoresis; dec in BP; to MD; who advised no more hep-B vax;
Enlarged lymph node on left side back of neck; Hives all over body; Hives all over body, extreme itching/burning; Hives all over body, extreme itching/burning; Trouble sleeping; Some additional wheezing; Itchy throat; Headaches; Extreme back pain; Arm rash; Arm rash/soreness; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 05May2021 at 14:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included Post-Traumatic Stress Disorder (PTSD), asthma, seasonal allergies, sciatica, Adrenocorticotropic Hormone (ACTH) deficiency, trichotillomania, agoraphobia, neurological disorders otherwise unspecified, Polycystic Ovarian Syndrome (PCOS), chronic kidney stones, early stage fatty liver changes, obesity, chronic insomnia, Irritable Bowel Syndrome with Diarrhea (IBS-D), Gastroesophageal Reflux Disease (GERD) and Deep Vein Thrombosis (DVT). The patient had no allergies to medications, food, or other products. Concomitant medications included pantoprazole sodium sesquihydrate (PROTONIX), budesonide, formoterol fumarate (SYMBICORT), levocabastine hydrochloride (ZYRTEC), salbutamol (VENTOLIN), zolpidem tartrate (AMBIEN) and ferrous sulfate (SLOW-FE), all taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05May2021 at 16:00, the patient experienced enlarged lymph node on left side back of neck, hives all over body, extreme itching/burning, trouble sleeping, some additional wheezing, itchy throat, headaches, extreme back pain and arm rash and soreness. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment with hydroxyzine, prednisone, recommendation Over The Counter (OTC) medications. The clinical outcome of the events enlarged lymph node on left side back of neck, hives all over body, extreme itching/burning, trouble sleeping, wheezing, itchy throat, headaches, extreme back pain and arm rash and soreness were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
I was hospitalized June 28, 2021 and found out I had an infection. They could not figure out where infection was coming from. On July 29, 2021 I was given a MRI and was told I have extreme Myocarditis. Doctor recommended I contact the CDC. As of October 14, 2021 I am still trying to recover.
On day 10, a large lesion appeared around the injection site.  It was 4 inches long and 2.5 inches wide, hot to the touch, itchy, swollen and hard.  This is not an uncommon reaction for me.  The same happens after flu shots.  The only difference was the lag in reaction from vaccination.  The lesion grew over a couple of days, but lessened in inflammation intensity.  This is day 13 and it is gradually fading away.
This spontaneous report was received from a physician refers to a patient of unknown demography. On 14-APR-2014, the patient was vaccinated with VARIVAX (Merck) Lot # J009729 (Expiry: 29-OCT-2014) (dose, route and frequency were not reported) and M-M-R II Lot # J003787 (Expiry: 07-JUN-2015) which were exposed to 13C for 68 hours. No adverse effects were reported. No further information was provided. This case is linked to the case 1404USA010752 and 1404USA010753 (same reporter link). Additional information has been requested.
After the 2nd dose, 3 weeks later, I notice pain in my back around my waist. It was a very sharp shooting pain. It just got progressively worse. I went to see my doctor on 6/24/2021. I did blood work and physical exam. He recommended physical therapy and took an x-ray. The x-ray showed a slight change in L4 and L5. I am currently having pain in my left thigh and right calf. I also have pain elsewhere in my body; back of the knees, back, and left foot. The pain comes and goes however the pain in my left thigh and right calf is constant. Physical therapy has helped to decrease the pain. I was prescribed Naproxen for 2 weeks and switched over to Advil now. I am being followed by PT and will do another X-ray this week.
Patient presents to clinic with redened area surrounding puncture site approximately 4cm x 6 cm no edema. Patient states that it is itchy and if she itches it, then it gets really red. Denies pain or limited arm movement. Patient instructed to monitor site for continued healing. Educated on signs of infection such as increased redness/swelling/fever. Instructed patient to see PCP if any of the symptoms occur.
got infected with COVID-19; got infected with COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 84-year-old female patient received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "got infected with COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: she got infected with COVID-19 and was prescribed Paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Rash, itching, burning, redness, swelling due to secondary skin infection caused by the COVID vaccination.
severe tight pain/ in a lot of pain; Muscle kept twitching that is very painful/ Twitching affecting all of her muscles; Arm is really tired and she is unable to brush her hair; cramps in her stomach; Left eye keeps twitching; Whole left leg from her knee to her ankle was really hard and solid, and it felt like it was tightening; Muscle contractions pretty much everywhere; Hard chest contractions; Has a lot of discomfort; Arm was a little tender the first day; runny nose; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Has a lot of discomfort), TENDERNESS (Arm was a little tender the first day), PAIN (severe tight pain/ in a lot of pain), MUSCLE TWITCHING (Muscle kept twitching that is very painful/ Twitching affecting all of her muscles) and MOBILITY DECREASED (Arm is really tired and she is unable to brush her hair) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced DISCOMFORT (Has a lot of discomfort), TENDERNESS (Arm was a little tender the first day) and RHINORRHOEA (runny nose). On 08-Mar-2021, the patient experienced PAIN (severe tight pain/ in a lot of pain), MUSCLE TWITCHING (Muscle kept twitching that is very painful/ Twitching affecting all of her muscles), MOBILITY DECREASED (Arm is really tired and she is unable to brush her hair), ABDOMINAL PAIN UPPER (cramps in her stomach), BLEPHAROSPASM (Left eye keeps twitching), PAIN IN EXTREMITY (Whole left leg from her knee to her ankle was really hard and solid, and it felt like it was tightening), MUSCLE CONTRACTIONS INVOLUNTARY (Muscle contractions pretty much everywhere) and CHEST PAIN (Hard chest contractions). On 07-Mar-2021, TENDERNESS (Arm was a little tender the first day) had resolved. On 09-Mar-2021, PAIN (severe tight pain/ in a lot of pain), MUSCLE TWITCHING (Muscle kept twitching that is very painful/ Twitching affecting all of her muscles), MOBILITY DECREASED (Arm is really tired and she is unable to brush her hair), ABDOMINAL PAIN UPPER (cramps in her stomach), PAIN IN EXTREMITY (Whole left leg from her knee to her ankle was really hard and solid, and it felt like it was tightening), MUSCLE CONTRACTIONS INVOLUNTARY (Muscle contractions pretty much everywhere) and CHEST PAIN (Hard chest contractions) had resolved. At the time of the report, DISCOMFORT (Has a lot of discomfort), BLEPHAROSPASM (Left eye keeps twitching) and RHINORRHOEA (runny nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications and treatment medications were reported.
pt states that she felt fine after taking the vax except her arm was a little sore and she had some fatigue and slight fever.   On 4/6/2021 she said she developed a itchy red rash on chest and both arms.  The next day the chest was covered with hives and that were also on both thighs and hands.  Pt used Benadryl spray which stopped the itching.  Pt contacted her PCP which called her in a RX for prednisone.  Pt says today 4/8/2021 rash is still present but hives are gone and it seems to be clearing up.
6-7 itchy rash on torso, chest, neck; started BENADRYL. 6-9 a little better.
1-9-15 Client phoned health unit to complain of left arm pain that started 4 to 5 hours after receiving flu shot. She took inflammation and pain med. Next day c/o lower back pan and left arm pain. Rub - ICY HOT on lower back. Today 1-12-15 still c/o being a little sore to left arm and back.
expired vaccine administered. vaccine expired on 11/1/21, it was administered 4 days past expiration date on 11/5/21
received 2 doses of Shignrix in 24 hours; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 95-year-old male patient who received Herpes zoster (Shingrix) (batch number FZ7Z4, expiry date 27th January 2023) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 25th August 2021, the patient received the 2nd dose of Shingrix. In August 2021, unknown after receiving Shingrix and Shingrix, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown.  Additional details were reported as follows: This case was reported by the Nurse. The age at vaccination was not reported. The nurse reported that, the patient received two doses of shingrix withing 24 hours, which led to overdose  The reporter did not consent to followup.
This case was reported by a other health professional and described the occurrence of herpes simples type I in a adult female healthcare professional who intended to vaccinate the patient with SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 4 days after receiving SHINGRIX, the patient experienced herpes simples type I, inadvertent exposure to vaccine and exposure via skin contact. On an unknown date, the outcome of the herpes simplex type I, inadvertent exposure to vaccine and exposure via skin contact were unknown. It was unknown if the reporter considered the herpes simplex type I to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient for herself. The age at vaccination was not reported. The reporter was a health care provider and during reconstitution while removing the needle, the vacuum suction caused it to splash on her hands, which led to inadvertent exposure to vaccine and exposure via skin contact. Four days after vaccination, the healthcare provider was tested positive for herpes simplex virus type type I (HSV1 and she had negative antibodies so that means it was new virus to her). The healthcare provider had not had any exposure to contract the virus in the 14 day window for a new first time outbreak. The reporter was asking if the SHINGRIX could cause the HSV virus if the vaccine came in contact with skin.
This spontaneous report was received from a registered nurse refers to an unknown number of children patients with unspecified age, gender, pertinent medical history or drug reaction / allergies. On an unspecified date, the patients were vaccinated with improperly stored VARIVAX (Merck) (dose, lot numbers were not reported). No other co-suspects were reported. No concomitant medications were reported. Treatment was not reported. The patients' outcome were not reported. No adverse effects reported at this time. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. This is a report from several reports from the same source. Additional information has been requested.
Headache, NauseaVomiting, CHILLS, ABDOMINAL PAIN, JITTERY Narrative:
I have had severe body aches that lasted for 2 days and milder body aches that still continue. My arm that I had the shots in has been in a lot of pain and I can hardly use it to get dressed or do anything. I have had the flu shot for 18 years in a row so not sure why my arm is so bad other than if the pneumonia shot caused it.
Caller stated that unlike the other times, she has been having very strong effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Caller stated that unlike the other times, she has been having very strong effects) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced VACCINATION COMPLICATION (Caller stated that unlike the other times, she has been having very strong effects). At the time of the report, VACCINATION COMPLICATION (Caller stated that unlike the other times, she has been having very strong effects) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication were given. No treatment information were given.   This case was linked to MOD-2021-404313, MOD-2021-404716 (Patient Link).
some swelling on his arm; This is a spontaneous report from a non-contactable consumer (patient). A male patient of an unspecified age received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- unknown) via an unspecified route of administration on the second week in May2021 as unknown single for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, patient stated he sustained some swelling on his arm and he infused twice after to treat the swelling. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a health professional concerning a female infant who was vaccinated with a dose of ROTATEQ. Subsequently the patient spit up. No product quality complaint was involved. No other information was provided. This is one of two reports from the same source. Additional information has been requested.
Approximately 2 hours after receiving influenza vaccine, patient returns to clinic with hives to face and neck. Denies SOB/difficulty breathing. Patient assessed by provider and released home with BENADRYL.
Excruciating pain (9 on scale of 0-10; unable to move arm), chills, low fever (94 degrees F). Pain started a few hours after injection and continued for approximately 24 hours unabated, after which pain subsided somewhat. For the next 24 hours pain was still extreme (8 on scale of 0-10) though the range of motion in my arm increase a bit. After approximately 48 hours pain was dramatically reduced, and by day 3 I was near 100%. The magnitude of pain (9 out of 10) is why I thought it would be useful to report the event. The pharmacist said I should expect a lot of pain, but a complete in ability to move my arm due to searing pain seemed exceptional. The pain was so intense it caused dizziness and nausea as well.
14July pt exp involuntary abdominal contractions,low grade fever(unspecified) & local sx.
itching on cheek and neck, redness (flushing). Evaluated  by EMS-Cleared
Varicella #2 given per order of travel MD. Returned in 2 days with swelling & discomfort at injection site. No temperature. No signs of infection at this time. Seen by Dr.
Patients arm broke out in a rash. The patient said the rash showed up that night or later that day. She came in and showed me on 10/11 and said that the rash was going away and feeling better.
44yr old patient with history of HTN (on amlodipine-omesartan), prediabetes, obesity and other comorbidities presented for office visit on 9/27/2021.  During visit, MD ordered Tdap vaccine greater than or equal to 7yo IM (BOOSTRIX/ADACEL).  CMA administered Boostrix Tdap (LOT # 59TH3) IM in patient's left deltoid.  On 9/28, patient contacted RN triage line noting blood in urine that morning with painful/burning with urination.  Patient presented to urgent care.  Urine analysis showed + blood, urine culture mixed flora (likely contamination).  UC PA prescribed ciprofloxacin.  Per notes, patient denied hematuria during follow up call on 9/29.  Appointment with Urology (scheduled for 10/8/21) canceled.  Reporter n .  Reporter notes undergoing cystoscopy and MRI (unable to verify).  Patient sent message 1/31/22 requesting information regarding lot and drug company of Tdap vaccine administered.  Information provided by office staff.  No indication that vaccine administration causes hematuria.
felt heart racing HR 125, 115, BP 133/83, BP 125/82, 99% oxygen sats. sat for 45 minutes prior to leaving
No adverse event; Patient of 6 months-5 years of age received a Moderna COVID-19, bivalent vaccine from the Pink cap vial(10 mcg) instead of blue cap vial(25 mcg), when blue cap was indicated; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient of 6 months-5 years of age received a Moderna COVID-19, bivalent vaccine from the Pink cap vial(10 mcg) instead of blue cap vial(25 mcg), when blue cap was indicated) and NO ADVERSE EVENT (No adverse event) in an infant female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. 216K22A and 216K22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 12-May-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 10 microgram. On 10-Jun-2023, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 10 microgram. In 2023, the patient experienced WRONG PRODUCT ADMINISTERED (Patient of 6 months-5 years of age received a Moderna COVID-19, bivalent vaccine from the Pink cap vial(10 mcg) instead of blue cap vial(25 mcg), when blue cap was indicated). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient of 6 months-5 years of age received a Moderna COVID-19, bivalent vaccine from the Pink cap vial(10 mcg) instead of blue cap vial(25 mcg), when blue cap was indicated) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient of 6 months-5 years of age received a Moderna COVID-19, bivalent vaccine from the Pink cap vial(10 mcg) instead of blue cap vial(25 mcg), when blue cap was indicated).    The route of administration of suspect Moderna bivalent was reported as BI. Concomitant medications were not reported.  No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-730780 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-730780:Master case,
Chills and low grade fever woke me up at around 3am Wednesday. I took 2 ibuprofen and put a cold pack on my head and woke up later I was fine.